NSAID Use in Elderly Patients
Introduction to Risks
- The American Geriatrics Society and other guideline societies recommend that NSAIDs should not be used in elderly patients without gastroprotection for any duration, as gastrointestinal toxicity is both dose-related and time-dependent, with risk increasing continuously even with short-term use 1, 2
Evidence for Time-Dependent Risk
- Gastrointestinal toxicity of NSAIDs is explicitly time-dependent, with mucosal damage developing continuously rather than plateauing after an initial period 1, 2
- The annual incidence of NSAID-related upper gastrointestinal events ranges from 2.0% to 4.5%, with risk of bleeding, perforation, or obstruction at 0.2% to 1.9% annually 3, 4
Risk Stratification in Elderly Patients
- Advanced age (≥60 years) is itself a major risk factor for upper gastrointestinal bleeding and perforation 5, 6
- Among elderly veterans, NSAID exposure increases risk of upper gastrointestinal event-related mortality 3-fold, even after adjustment for age and comorbidity 3, 4
- Patients aged 65 years and older constitute 87.1% of the high-risk subset for NSAID-related complications 3, 4
Gastroprotection Strategies
- Proton pump inhibitors (PPIs) are the preferred gastroprotective agents and should be co-prescribed with NSAIDs 5, 6, 8
- Misoprostol is an alternative gastroprotective agent, though PPIs are better tolerated 5, 1, 2
Special Considerations
- Concomitant use of low-dose aspirin increases annual upper gastrointestinal event risk to 5.6%, making gastroprotection mandatory from day one 3, 4
- Concurrent corticosteroid or anticoagulant therapy eliminates any margin for unprotected NSAID use 5, 6
- History of peptic ulcer disease or gastrointestinal bleeding requires immediate gastroprotection 5, 6